Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | DPP4 | P27487 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL26660336 | 0.99 | KDM4E (0.44) | KDM4EHSP90AA1HSD17B10ALDH1A1NPC1 | |
| Hydrochloric Acid SCHEMBL32661050 | 0.99 | KDM4E (0.44) | KDM4EHSP90AA1HSD17B10ALDH1A1NPC1 | |
| Hydrochloric Acid SCHEMBL26660213 | 0.99 | KDM4E (0.44) | KDM4EHSP90AA1HSD17B10ALDH1A1NPC1 | |
| SCHEMBL26660304 | 0.78 | ABCB1 (0.40) | KDM4EALDH1A1HPGDALOX15 | |
| SCHEMBL26660309 | 0.78 | ABCB1 (0.40) | KDM4EALDH1A1HPGDALOX15 | |
| SCHEMBL30638641 | 0.78 | ABCB1 (0.40) | KDM4EALDH1A1HPGDALOX15 | |
| SCHEMBL12524199 | 0.77 | KDM4E (0.46) | KDM4EHSP90AA1HSD17B10ALDH1A1NPC1 | |
| SCHEMBL26660217 | 0.77 | KDM4E (0.37) | KDM4EALDH1A1NPC1HPGDALOX15 | |
| SCHEMBL26660211 | 0.77 | KDM4E (0.37) | KDM4EALDH1A1NPC1HPGDALOX15 | |
| SCHEMBL25155336 | 0.76 | HPGD (0.47) | KDM4EHSD17B10ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015325-A1 | ALKOXY HETEROARYL- CARBOXAMIDE OR THIOAMIDE COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2026-01-15 | — | — | US | disclosed |
| EP-4522592-A1 | ALKOXY HETEROARYL- CARBOXAMIDE OR THIOAMIDE COMPOUNDS | Syngenta Crop Protection AG (CH) | 2025-03-19 | — | — | EP | disclosed |
| WO-2023217989-A1 | ALKOXY HETEROARYL- CARBOXAMIDE OR THIOAMIDE COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2023-11-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015325-A1 | ALKOXY HETEROARYL- CARBOXAMIDE OR THIOAMIDE COMPOUNDS | CYCS, CBR3, CBR1 | KDM4E 3892/4885HSP90AA1 2165/4885HSD17B10 1947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.